UiPath, Inc. (PATH) News

UiPath, Inc. (PATH): $12.44

-0.77 (-5.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PATH to Watchlist
Sign Up

Filter PATH News Items

PATH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

PATH News Highlights

  • PATH's 30 day story count now stands at 34.
  • Over the past 20 days, the trend for PATH's stories per day has been choppy and unclear. It has oscillated between 1 and 10.
  • The most mentioned tickers in articles about PATH are ROSE, PRE and ARR.

Latest PATH News From Around the Web

Below are the latest news stories about UIPATH INC that investors may wish to consider to help them evaluate PATH as an investment opportunity.

Where Will UiPath Stock Be in 1 Year?

UiPath's (NYSE: PATH) stock jumped 12% on Dec. 2 after the automation software provider posted its latest quarterly report. Does that earnings beat indicate that UiPath has finally reached an inflection point after losing about two-thirds of its value over the past year? UiPath develops robotic process automation (RPA) services that can be integrated into an organization's software infrastructure.

Yahoo | December 5, 2022

UiPath Third Quarter 2023 Earnings: Beats Expectations

UiPath ( NYSE:PATH ) Third Quarter 2023 Results Key Financial Results Revenue: US$262.7m (up 19% from 3Q 2022). Net...

Yahoo | December 5, 2022

Why Is UiPath (PATH) Stock Rising 12% Today?

With UiPath delivering an outstanding Q3 earnings report, the news not only bolstered PATH stock but gave the software sector a lift.

Josh Enomoto on InvestorPlace | December 2, 2022

Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket

Gainers Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ) shares rose 44.7% to $0.9902 in pre-market trading after the company reported the U.S. FDA approval of REZLIDHIA (olutasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation. MEI Pharma, Inc. (NASDAQ: MEIP ) shares rose 22.2% to $0.40 in pre-market trading. The company, last month, posted a narrower quarterly loss. Ra Medical Systems, Inc. (NYSE: RMED ) rose 17.7% to $3.73 in pre-market trading after jumping 29% on Thursday. Ra Medical Systems, last month, posted a Q3 loss of $4.36 per share. Helbiz, Inc. (NASDAQ: HLBZ ) rose 13.3% to $0.2450 in pre-market trading. Helbiz Kitchen, a part of Helbiz, partnered to bring food delivery to United States with Kitchen Un...

Benzinga | December 2, 2022

UiPath stock jumps after Q3 beats (NYSE:PATH)

UiPath (PATH) shares rose 14% on Friday after the automation software company reported better-than-expected third quarter results.The firm generated adjusted earnings of $0.05 per share…

Seeking Alpha | December 2, 2022

Here''s Why Cathie Wood Favorite UiPath Stock Jumped Today

Growth in the most recent quarter was better than expected, but the future growth picture is cloudy.

The Motley Fool | December 2, 2022

UiPath Inc. (NYSE:PATH) Plunging -34.22% In 6 Months – Here’s What To Expect

UiPath Inc. (NYSE:PATH)’s traded shares stood at 7.61 million during the last session. At the last check today, the stock’s price was $14.71, to imply an increase of 13.85% or $1.79 in intraday trading. The PATH share’s 52-week high remains $48.68, putting it -230.93% down since that peak but still an impressive 29.3% since price … UiPath Inc. (NYSE:PATH) Plunging -34.22% In 6 Months – Here’s What To Expect Read More »

Marketing Sentinel | December 2, 2022

Here's Why Cathie Wood Favorite UiPath Stock Jumped Today

Growth in the most recent quarter was better than expected, but the future growth picture is cloudy.

Yahoo | December 2, 2022

2 Cloud Stocks Rising Up on Friday

The stock market got a bit of unexpected news early Friday that sent stock index futures sharply lower before the start of trading on Friday morning. The latest government employment report showed stronger job growth than many economists had expected, and that threw cold water on the idea that the Federal Reserve might quickly slow its pace of interest rate hikes. In particular, stocks of cloud companies UiPath (NYSE: PATH) and Samsara (NYSE: IOT) were up significantly after they released their latest financial reports.

Yahoo | December 2, 2022

11 Best Aggressive Stocks to Buy Now

In this article, we discuss the 11 best aggressive stocks to buy now. If you want to read about some more aggressive stocks, go directly to the 5 Best Aggressive Stocks to Buy Now. Aggressive stocks are high-risk, high-reward growth stocks that can provide investors with strong returns. Growth stocks offer a substantially higher growth […]

Yahoo | December 2, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5485 seconds.